GOLDMAN SACHS GROUP INC - MARINUS PHARMACEUTICALS INC ownership

MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 21 filers reported holding MARINUS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of MARINUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$974,000
+705.0%
383,292
+544.3%
0.00%
Q1 2020$121,000
-41.8%
59,492
-38.3%
0.00%
Q4 2019$208,000
+60.0%
96,366
+14.8%
0.00%
Q3 2019$130,000
-98.3%
83,929
-95.4%
0.00%
-100.0%
Q2 2019$7,605,000
-0.1%
1,832,429
+0.6%
0.00%0.0%
Q1 2019$7,612,000
+34.7%
1,821,017
-7.5%
0.00%0.0%
Q4 2018$5,650,000
+12.4%
1,968,694
+291.6%
0.00%
+100.0%
Q3 2018$5,027,000
+2401.0%
502,686
+1668.9%
0.00%
Q2 2018$201,000
-64.2%
28,418
-80.7%
0.00%
Q1 2018$562,000
+84.3%
147,229
+294.3%
0.00%
Q4 2017$305,000
+1806.2%
37,344
+200.8%
0.00%
Q2 2016$16,000
-97.5%
12,415
-83.9%
0.00%
Q3 2015$641,000
-48.0%
76,881
-27.6%
0.00%
Q2 2015$1,232,000
+721.3%
106,187
+536.7%
0.00%
Q1 2015$150,000
-21.5%
16,677
-7.8%
0.00%
Q4 2014$191,000
-44.2%
18,080
-65.8%
0.00%
Q3 2014$342,00052,9080.00%
Other shareholders
MARINUS PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 5,042,735$21,079,0008.43%
VHCP Management III, LLC 1,258,964$5,262,0003.07%
Granite Point Capital Management, L.P. 3,045,407$12,730,0001.23%
VHCP Management II, LLC 743,876$3,109,0000.91%
Endurant Capital Management LP 437,299$1,828,0000.72%
683 Capital Management, LLC 1,400,000$5,852,0000.53%
Granite Point Capital Management, L.P. 800,000$3,344,0000.32%
Fosun International Ltd 390,860$1,540,0000.10%
Caption Management, LLC 250,000$1,045,0000.06%
Tekla Capital Management LLC 328,436$1,373,0000.06%
View complete list of MARINUS PHARMACEUTICALS INC shareholders